Yoshida, Chikashi
Yamaguchi, Hiroki
Doki, Noriko
Murai, Kazunori
Iino, Masaki
Hatta, Yoshihiro
Onizuka, Makoto
Yokose, Norio
Fujimaki, Katsumichi
Hagihara, Masao
Oshikawa, Gaku
Murayama, Kayoko
Kumagai, Takashi
Kimura, Shinya
Najima, Yuho
Iriyama, Noriyoshi
Tsutsumi, Ikuyo
Oba, Koji
Kojima, Hiroshi
Sakamaki, Hisashi
Inokuchi, Koiti
,
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 10 October 2022
Revised: 21 January 2023
Accepted: 22 January 2023
First Online: 4 February 2023
Declarations
:
: CY received research funding from BMS and honoraria from BMS, Novartis, Pfizer, Janssen, Chugai, Ono, Otsuka, AbbVie, Nippon Shinyaku, and Takeda and from advisory board of Novartis and AbbVie. HY received research funding from BMS and Otsuka; consulting fee from Novartis; and honoraria from Novartis, Otsuka, and Pfizer. ND received honoraria from Novartis and Janssen. KM received honoraria from BMS, Otsuka, Chugai, Ono, Novartis, Pfizer, and Takeda. YH received honoraria from BMS. MO received honoraria from Novartis, Pfizer, Otsuka, Jansen, and Nihon Shinyaku. NY received research funding from Chugai, Kyowa Kirin, and Takeda and honoraria from BMS. KF received honoraria from BMS, Novartis, Pfizer, Nippon Shinyaku, Meiji Seika, CSL Behring, Otsuka, AbbVie, Jansen, Chugai, and Takeda. GO received honoraria from BMS, Novartis, Pfizer, Nippon Shinyaku, Kyowa Kirin, Celgene, SymBio, Sanofi, Ono, Meiji, Nippon Kayaku, Alexion, Otsuka, AbbVie, Janssen, Chugai, Astellas, Sumitomo Dainippon, Takeda, Eisai, MSD, Mundiphama, and AstraZeneca. TK received honoraria from BMS, Novartis, Chugai, Ono, and Pfizer. SK received research funding from BMS and Pfizer and honoraria from BMS, Novartis, Pfizer, and Otsuka. NI received honoraria from BMS, Novartis, Pfizer, and Otsuka. IT received research funding from National Hospital Organization and honoraria from Life Science Publications and Medical View. KO received honoraria from Chugai and Daiichi Sankyo and payment from Takeda and from data safety monitoring/advisory board of Ono, Eisai, and Janssen. HK received honoraria from Taiho, AbbVie, AstraZeneca, and Chugai. KI received research funding from BMS and honoraria from BMS, Otsuka, and Novartis. MI, MH, KM, YN, and HS have nothing to disclose.